New registry tracks artificial sphincter success for female incontinence

NCT ID NCT04114266

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This registry follows 180 women receiving an artificial urinary sphincter for stress incontinence caused by a weak sphincter. Researchers measure how many become dry (using no pads or just one light pad) and how long that dryness lasts over 5 years. Participants also report on sexual function and quality of life through questionnaires.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Artificial urinary sphincter surgery
What this could lead to
If successful, this registry could confirm that artificial urinary sphincter surgery is a reliable option for women with severe stress incontinence, improving continence and quality of life.
What could go wrong
This is an observational registry, not a controlled trial, so results may not prove cause and effect. Surgery carries risks like infection, device malfunction, or need for revision.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOWER URINARY TRACT SYMPTOMS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

female stress incontinence Lower Urinary Tract Symptoms urethral intrinsic sphincter deficiency Urinary Incontinence Urinary Incontinence, Stress urinary system disorder Urination Disorders

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Addenbrooks Hospital

    Cambridge, United Kingdom

  • CHU Nancy

    Vandœuvre-lès-Nancy, France

  • CHU Rangueil

    Toulouse, France

  • CHU de Lille

    Lille, France

  • CHU de Limoges

    Limoges, France

  • Clinique urologique CHU de NANTES

    Nantes, France

  • Hospital de La Princesa

    Madrid, Spain

  • Hôpital Lyon Sud

    Lyon, France

  • Hôpital de la Pitié-Salpêtrière

    Paris, France

  • Hôpital la Conception

    Marseille, France

  • Klinikum Lippe

    Detmold, Germany

  • Maastricht UMC+

    Maastricht, Netherlands

  • Marqués de Valdecilla University Hospital

    Santander, Spain

  • Thomayer Hospital

    Prague, Czechia

  • Universitair Ziekenhuis Gent

    Ghent, Belgium

  • University Hospital Bordeaux

    Bordeaux, France

  • University Hospital Leuven

    Leuven, 3000, Belgium

  • University Hospital of Nimes

    Nîmes, France

  • University of Rennes, Department of Urology

    Rennes, 35000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.